Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Aravive Shareholders Equity (Quarterly): 1.701M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.701M |
| June 30, 2023 | -19.82M |
| March 31, 2023 | -38.61M |
| December 31, 2022 | 10.66M |
| September 30, 2022 | 15.04M |
| June 30, 2022 | 30.07M |
| March 31, 2022 | 39.20M |
| December 31, 2021 | 42.22M |
| September 30, 2021 | 54.34M |
| June 30, 2021 | 64.06M |
| March 31, 2021 | 68.72M |
| December 31, 2020 | 48.06M |
| September 30, 2020 | 49.37M |
| June 30, 2020 | 59.45M |
| March 31, 2020 | 59.00M |
| December 31, 2019 | 69.05M |
| September 30, 2019 | 47.53M |
| June 30, 2019 | 52.87M |
| March 31, 2019 | 54.96M |
| December 31, 2018 | 59.94M |
| Date | Value |
|---|---|
| September 30, 2018 | 63.72M |
| June 30, 2018 | 68.94M |
| March 31, 2018 | 76.63M |
| December 31, 2017 | 82.76M |
| September 30, 2017 | 49.24M |
| June 30, 2017 | 95.02M |
| March 31, 2017 | 126.50M |
| December 31, 2016 | 151.07M |
| September 30, 2016 | 111.00M |
| June 30, 2016 | 135.74M |
| March 31, 2016 | 154.70M |
| December 31, 2015 | 176.50M |
| September 30, 2015 | 194.18M |
| June 30, 2015 | 212.25M |
| March 31, 2015 | 227.58M |
| December 31, 2014 | 167.37M |
| September 30, 2014 | 181.23M |
| June 30, 2014 | 193.47M |
| March 31, 2014 | 201.10M |
| December 31, 2013 | 10.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-38.61M
Minimum
Mar 2023
69.05M
Maximum
Dec 2019
36.27M
Average
47.79M
Median
Shareholders Equity (Quarterly) Benchmarks
| Esperion Therapeutics Inc | -294.30M |
| Processa Pharmaceuticals Inc | 8.883M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.05M |
| Total Liabilities (Quarterly) | 11.35M |
| Current Ratio | 0.978 |